Insight Financial Statements From 2010 to 2025

Stocks . USA . 
Stock . Insight Molecular Diagnostics
IMDX Stock   6.37  0.55  9.45%   
Insight Molecular's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Insight Molecular's valuation are provided below:
Gross Profit
2.1 M
Market Capitalization
86.7 M
Enterprise Value Revenue
14.1147
Revenue
3.8 M
Earnings Share
(3.79)
We have found one hundred twenty available fundamental trends for Insight Molecular, which can be analyzed and compared to other ratios and to its competitors. All investors should make sure to confirm all of Insight Molecular regular market performance against the performance between 2010 and 2025 to make sure the company can sustain itself down the road.

Insight Molecular Total Revenue

1.71 Million

Check Insight Molecular financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Insight Molecular's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.4 M, Selling General Administrative of 11.5 M or Other Operating Expenses of 66.1 M, as well as many indicators such as Price To Sales Ratio of 15.71, Dividend Yield of 0.0015 or Days Sales Outstanding of 239. Insight financial statements analysis is a perfect complement when working with Insight Molecular Valuation or Volatility modules.
  
Build AI portfolio with Insight Stock
Check out the analysis of Insight Molecular Correlation against competitors.

Insight Molecular Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets48.3 M35.1 M37.5 M
Slightly volatile
Short and Long Term Debt Total4.1 M3.7 M3.6 M
Slightly volatile
Other Current Liabilities4.8 M3.7 M3.9 M
Slightly volatile
Total Current Liabilities7.6 M7.3 M6.5 M
Slightly volatile
Property Plant And Equipment Net3.7 M2.8 M2.8 M
Slightly volatile
Accounts Payable2.4 M2.3 M699.6 K
Slightly volatile
Cash12.3 M8.6 M9.2 M
Slightly volatile
Non Current Assets Total32.8 M23.3 M25.1 M
Slightly volatile
Non Currrent Assets Other5.1 M4.3 M3.5 M
Slightly volatile
Cash And Short Term Investments13.8 M8.6 M11.2 M
Slightly volatile
Common Stock Shares Outstanding13.7 M13.1 M3.7 M
Slightly volatile
Liabilities And Stockholders Equity48.3 M35.1 M37.5 M
Slightly volatile
Other Current Assets1.1 M1.1 M844.7 K
Slightly volatile
Total Liabilities29.2 M47.4 M22.6 M
Slightly volatile
Total Current Assets15.5 M11.8 M12.4 M
Slightly volatile
Short Term Debt1.6 M1.3 M2 M
Slightly volatile
Intangible Assets23.7 M14.6 M17.2 M
Slightly volatile
Common Stock355.2 M338.2 M132.8 M
Slightly volatile
Non Current Liabilities Total28.8 M40.1 M16.6 M
Slightly volatile
Net Receivables1.3 M1.6 M565.2 K
Slightly volatile
Capital Lease Obligations2.9 M3.7 M4.1 M
Slightly volatile
Property Plant And Equipment Gross12.4 M14 M9.3 M
Slightly volatile
Short and Long Term Debt1.1 M1.2 M1.3 M
Slightly volatile
Capital Stock329 M338.2 M269.2 M
Slightly volatile
Non Current Liabilities Other40 M37.7 M67.7 M
Slightly volatile
Net Working Capital4.3 M4.5 M20.4 M
Slightly volatile

Insight Molecular Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization1.4 M1.6 M1.1 M
Slightly volatile
Selling General Administrative11.5 M13.1 M8.7 M
Slightly volatile
Other Operating Expenses66.1 M62.9 M22.3 M
Slightly volatile
Research Development7.2 M9.8 M5.9 M
Slightly volatile
Total Operating Expenses64.9 M61.8 M21.8 M
Slightly volatile
Interest Expense146.1 K84 K100.9 K
Slightly volatile
Selling And Marketing Expenses1.2 M641 K1.1 M
Pretty Stable
Cost Of Revenue879.2 K1.1 M643 K
Slightly volatile
Total Revenue1.7 M1.9 M1.4 M
Slightly volatile
Reconciled Depreciation2.5 M1.6 M3.8 M
Slightly volatile

Insight Molecular Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation3.7 M1.9 M2.8 M
Slightly volatile
Begin Period Cash Flow12.8 M11.1 M9.7 M
Slightly volatile
Depreciation1.4 M1.6 M1.1 M
Slightly volatile
Capital Expenditures943.3 K516 K706.8 K
Slightly volatile
End Period Cash Flow13.6 M10.3 M10.2 M
Slightly volatile
Total Cash From Financing Activities28.7 M20.4 M21.8 M
Slightly volatile
Dividends Paid76.8 K86.4 K94.2 K
Slightly volatile
Issuance Of Capital Stock31.5 M27.8 M65.4 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio15.7116.538599.0954
Slightly volatile
Dividend Yield0.00150.00170.0018
Slightly volatile
Days Sales Outstanding239313147
Slightly volatile
Stock Based Compensation To Revenue0.971.0174.1114
Pretty Stable
Capex To Depreciation0.50.32990.5169
Pretty Stable
EV To Sales13.213.895397.4181
Slightly volatile
Inventory Turnover3.043.219.1922
Slightly volatile
Days Of Inventory On Hand11211883.1973
Slightly volatile
Payables Turnover0.480.50071.6033
Pretty Stable
Sales General And Administrative To Revenue13.416.987813.2757
Pretty Stable
Research And Ddevelopement To Revenue7.335.23077.5761
Slightly volatile
Capex To Revenue0.260.27431.0858
Very volatile
Cash Per Share0.630.66073.6743
Very volatile
Days Payables Outstanding765729361
Slightly volatile
Income Quality0.470.34140.5136
Slightly volatile
Intangibles To Total Assets0.290.41640.3358
Slightly volatile
Current Ratio2.461.61642.0278
Pretty Stable
Receivables Turnover1.111.16624.5799
Slightly volatile
Capex Per Share0.03750.03950.1737
Slightly volatile
Revenue Per Share0.140.14390.3271
Slightly volatile
Interest Debt Per Share0.270.28671.1178
Very volatile
Debt To Assets0.09920.10440.2188
Slightly volatile
Operating Cycle390444215
Slightly volatile
Days Of Payables Outstanding765729361
Slightly volatile
Ebt Per Ebit0.90.99381.08
Pretty Stable
Effective Tax Rate0.170.160.0579
Slightly volatile
Long Term Debt To Capitalization0.04710.04960.124
Slightly volatile
Quick Ratio2.441.562.0108
Pretty Stable
Net Income Per E B T1.311.011.2177
Slightly volatile
Cash Ratio1.431.18711.4359
Slightly volatile
Days Of Inventory Outstanding11211883.1973
Slightly volatile
Days Of Sales Outstanding239313147
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.831.02491.0256
Slightly volatile
Fixed Asset Turnover0.720.68230.2547
Slightly volatile
Debt Ratio0.09920.10440.2188
Slightly volatile
Price Sales Ratio15.7116.538599.0954
Slightly volatile
Asset Turnover0.05630.05360.0247
Slightly volatile

Insight Molecular Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap192.4 M202.5 M1.4 B
Slightly volatile
Enterprise Value198.6 M209 M1.5 B
Slightly volatile

Insight Fundamental Market Drivers

About Insight Molecular Financial Statements

Insight Molecular investors use historical fundamental indicators, such as Insight Molecular's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Insight Molecular. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue5.9 M6.2 M
Cost Of Revenue1.1 M879.2 K
Total Revenue1.9 M1.7 M
Stock Based Compensation To Revenue 1.02  0.97 
Sales General And Administrative To Revenue 6.99  13.41 
Research And Ddevelopement To Revenue 5.23  7.33 
Capex To Revenue 0.27  0.26 
Revenue Per Share 0.14  0.14 
Ebit Per Revenue(32.45)(34.07)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
DDDupont De Nemours
CRDOCredo Technology Group
GOOGAlphabet Inc Class C

Additional Tools for Insight Stock Analysis

When running Insight Molecular's price analysis, check to measure Insight Molecular's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Insight Molecular is operating at the current time. Most of Insight Molecular's value examination focuses on studying past and present price action to predict the probability of Insight Molecular's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Insight Molecular's price. Additionally, you may evaluate how the addition of Insight Molecular to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2025 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY